期刊
THORACIC CANCER
卷 13, 期 5, 页码 659-663出版社
WILEY
DOI: 10.1111/1759-7714.14335
关键词
adjuvant radiotherapy; lung cancer; IIIA-N2 disease
资金
- Zhejiang Natural Science Foundation [LQ20H160020]
The role of adjuvant radiotherapy in completely resected pIIIA-N2 NSCLC is controversial. Previous studies have shown that postoperative radiotherapy can reduce local recurrence and prolong disease-free survival, but recent randomized controlled trials have shown no survival benefit. We need to reassess the value of postoperative radiotherapy.
The role of adjuvant radiotherapy in completely resected pIIIA-N2 non-small cell lung cancer (NSCLC) has long been debated. Evidence from previous retrospective and prospective studies showed that postoperative radiotherapy could reduce the incidence of local recurrence and prolong disease-free survival, while two recently reported randomized controlled trials (lung ART and PORT-C) both demonstrated no survival benefit of postoperative radiotherapy. The great gap between our knowledge and reality has made us rethink the value of postoperative radiotherapy. In this mini review, we elaborate on the role of postoperative radiotherapy in completely resected pIIIA-N2 NSCLC.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据